Is it possible to use riamilovir to prevent infection and treat COVID-19?
https://doi.org/10.37489/2588-0519-2020-S4-15-17
Abstract
Routine clinical use of riamilovir in COVID-19 is not recommended. The use of riamilovir is possible in clinical trials.
About the Authors
V. M. Tsvetov
Federal Center for Cardiovascular Surgery of the Ministry of Health of Russia
Russian Federation
Russian Federation
Tsvetov Vitaly M. – Candidate of Medical Sciences, Doctor — Clinical Pharmacologist. SPIN code: 3202-7659
Chelyabinsk
K. B. Mirzaev
Russian Medical Academy of Continuing Professional Education of the Ministry of Health of Russia
Russian Federation
Russian Federation
Mirzaev Karin B. – Candidate of Medical Sciences, Associate Professor of the Department of Clinical Pharmacology and Therapy. SPIN code: 8308-7599
Moscow
D. A. Sychev
Russian Medical Academy of Continuing Professional Education of the Ministry of Health of Russia
Russian Federation
Russian Federation
Sychev Dmitry A. – Doctor of Medical Sciences, Professor, Corresponding Member RAS, Rector, Head. Department of Clinical Pharmacology and Therapy. SPIN code: 4525-7556
Moscow
References
1. Государственный реестр лекарственных средств. Инструкция по медицинскому Применению Триазавирина. http://grls.rosminzdrav.ru/GRLS.aspx?RegNumber=&MnnR=&lf=&TradeNmR=Триазавирин&OwnerName=&MnfOrg=&MnfOrgCountry=&isfs=0&isND=-1®type=1&pageSize=10&order=RegDate&orderType=desc&pageNum=1 (дата обращения: 01.05.2020)
2. Loginova SYa et al. Investigation of Triazavirin Antiviral Activity Against Tick-Borne Encephalitis Pathogen in Cell Culture. Antibiot Khimioter; 2014;59(1-2):3-5
3. Loginova SYa et al. Investigation of prophylactic efficacy of Triazavirin against experimental forest-spring encephalitis on albino mice. Antibiotics and chemotherapy. 2015;60(5-6):8-11. (In Russ).
4. Tikhonova EP et al. Possibility of including Triazavirin into complex treatment of tick-borne viral encephalitis in adults. Experimental and Clinical Pharmacology. 2018;81(9):21-25. (In Russ). DOI: 10.30906/08692092-2018-81-9-21-25
5. Kiselev OI et al. A New Antiviral Drug Triazavirin: Results of Phase II Clinical Trial. 2012;9-12. (In Russ).
6. https://apps.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR2000030001 (дата обращения: 01.05.2020)
7. http://www.chictr.org.cn/showproj.aspx?proj=49723 (дата обращения: 01.05.2020)
Review
For citations:
Tsvetov V.M., Mirzaev K.B., Sychev D.A. Is it possible to use riamilovir to prevent infection and treat COVID-19? Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2020;(4S):15-17. (In Russ.) https://doi.org/10.37489/2588-0519-2020-S4-15-17
Views:
21629
Email this article 